Heartmath Migraine Study
A Pilot Single-center Randomized Controlled Study of the Effects of Smartphone Based Heart Rate Variability Biofeedback in People With Migraine
1 other identifier
interventional
52
1 country
1
Brief Summary
This is a two arm study comparing smartphone based heart rate variability biofeedback using the HeartMath app and InnerBalance sensor to waitlist control on migraine quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 16, 2019
CompletedFirst Submitted
Initial submission to the registry
August 19, 2019
CompletedFirst Posted
Study publicly available on registry
September 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 16, 2020
CompletedAugust 24, 2020
August 1, 2020
7 months
August 19, 2019
August 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine whether there is any superiority between an 8-week program of app based HRV biofeedback (HeartMath) compared to wait list control in migraine quality of life
Measured by comparing the slope of reduction in MSQv2 scores
8 Weeks
Secondary Outcomes (3)
Change in depression
8 Weeks
Change in anxiety
8 Weeks
Change insomnia
8 Weeks
Study Arms (2)
HeartMath
EXPERIMENTALWaitlist Control
ACTIVE COMPARATORInterventions
HeartMath is a program where individuals learn heart rate variability biofeedback. Essentially, they learn breathing exercises that reduce their heart rate. The HeartMath program will be administered via an application on the smartphone and ear monitor.
Eligibility Criteria
You may qualify if:
- International Classification of Headache Disorders (ICHD) 3 criteria for migraine
- headache days/month
- Has not done behavioral therapy for migraine in the past year
- Has a smartphone and willing to try HRV biofeedback using an app and ear monitor
- English speaking
- HS graduate or higher level of education
- Patients must not make preventive medication changes for the course of the study. If patients just changed their preventive medication, they must wait a month before enrolling.
You may not qualify if:
- Doing any form of behavioral therapy for pain in the past year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NYU Langone Health
New York, New York, 10016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mia Minen, MD, MPH
New York Langone Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2019
First Posted
September 4, 2019
Study Start
June 16, 2019
Primary Completion
January 16, 2020
Study Completion
January 16, 2020
Last Updated
August 24, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- Requests should be directed to Mia.Minen@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).